On August 22, 2019, Israeli healthcare startup MDClone announced that it has closed a $26 million Series B funding round, led by health-tech venture capital fund aMoon, with additional funding from existing investors OrbiMed Israel Partners and Lightspeed Venture Partners.
According to MDClone, it has built what it says is the “first of its kind” — Healthcare Data Sandbox — that allows on-demand and self-service access to healthcare data, by protecting patient privacy, navigating complex IT systems through its patented “Synthetic Data Engine” and “Longitudinal Database”.
Together with this engine, the platform’s healthcare-oriented “data lake” and “discovery tool” provides a rapid and safe self-service environment for caregivers and researchers to understand any element of the care path for any population of interest.
“Every moment of every day there is a missed opportunity to use data to improve healthcare. MDClone’s solution unlocks data and with the newly added power of aMoon and continued support from OrbiMed and Lightspeed, we can turn data into a real strategic asset to transform care around the world,” said Ziv Ofek, Founder & CEO of MDClone and previously the founder of dbMotion, which was acquired by Allscripts in 2013 for $235 million.
“MDClone is resolving one of the greatest challenges in this emerging era of health-tech: centralizing, optimizing and enabling quick and easy access to health data, while preserving privacy and compliance,” said Yair Schindel, MD, Co-Founder and Managing Partner of aMoon. “We are honored to partner with Ziv Ofek and his outstanding team who will upgrade healthcare for millions globally.”
According to the company’s statement, MDClone will use this new funding opportunity to further develop its existing platform and build new products, as well as accelerate sales and marketing efforts.
Date: August 26, 2019